The science of life Ayurveda, not only deals with the prevention of diseases by maintaining health but also with the alleviation of diseases. In this ultra modern era due to change in lifestyles, sedentary works and food habits, people are unable to follow the Dinacharya and Ritucharya as explained in the classics, which may lead to different diseases. Due to improper postural habits, weight bearing and other unwholesome diets and habits there are higher the chances of discomfort and disease pertaining to spinal cord. Manyasthambha is one such condition that disturbs a big population due to today’s alterations in lifestyle. Here an effort is made to study and understand the role of Nasya Karma, Nasaapana and Shamanaushadhi like Vyoshadi Guggulu in the treatment aspect of this disease. Nasya Karma and Nasaapana provided highly significant results in all the symptoms of Manyasthambha. As per the clinical data, ‘Nasaapana is found to be more effective than Nasya Karma’. So it can be concluded that better results can be obtained with Shaddharana Yoga as Amapachana, Nasaapana with Mashabaladi Kwatha followed by Vyoshadi Guggulu as Shamanoushadhi.
Vatakantaka is characterized by the pain in the heel region and included in the vatavyadhi by Acharya Sushruta. It is common in about 10% of general population. Women are twice more prevalent than men. Vatakantaka is mainly caused due to vitiation of Vatadosha and continuous pressure on the heel region. It can be co-related with Calcaneal spur. It is more prevalent in female due to life style postures like standing for longer period, wearing high heel shoes. Various treatment measures for the management of Vatakantaka are given in the classics of Ayurveda. Siravyadha,Agnikarma and Eranda taila pana are the main chikitsa of Vatakantaka. Achrya Charaka said Vatakantaka is Sweda sadhya Vyadhi. So in this present study, treatment is given with swedana followed by Shamanoushadhi. Here 40 cases of Vatatakantaka vis- a -vis Calcaneal spur were devided in to two groups and subjected to Dashamula churna pinda sweda and valuka sweda for 7 days, followed by Nirgundi Guggulu for 30 days. Patients showed significant results in subjective and objective parameters. The present clinical study has been registered as a Prospective study in clinical trials registry- India (CTRI). Register number – CTRI/2019/11/022132
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.